These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1676526)

  • 21. Effects of non-competitive NMDA receptor antagonists on reproductive and motor behaviors in female rats.
    Fleischmann A; Vincent PA; Etgen AM
    Brain Res; 1991 Dec; 568(1-2):138-46. PubMed ID: 1839964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral and electrophysiological comparison of ketamine with dizocilpine in the rat.
    Kelland MD; Soltis RP; Boldry RC; Walters JR
    Physiol Behav; 1993 Sep; 54(3):547-54. PubMed ID: 8415949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The behavioral effects of NMDA antagonists in serotonin depleted rats.
    Płaźnik A; Jessa M; Nazar M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):159-66. PubMed ID: 9264085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An electrographic characterization of ketamine-induced linguopharyngeal motor activity.
    Marco LA; Reed TF; Aldes LD; Chronister RB
    Clin Neuropharmacol; 1988 Apr; 11(2):141-50. PubMed ID: 3378223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate.
    Dziki M; Hönack D; Löscher W
    Eur J Pharmacol; 1992 Nov; 222(2-3):273-8. PubMed ID: 1360405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA receptor antagonists change behavioral activity of rats treated with (S)-4CPG.
    Car H; Oksztel R; Nadlewska A; Wiśniewski K
    Pol J Pharmacol; 2001; 53(4):331-9. PubMed ID: 11990079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diphenylhydantoin potentiates the EEG and behavioural effects induced by N-methyl-D-aspartate antagonists in rats.
    Popoli P; Pèzzola A; Sagratella S
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):471-5. PubMed ID: 7862861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMDA antagonist inhibits rapid tolerance to ethanol.
    Khanna JM; Wu PH; Weiner J; Kalant H
    Brain Res Bull; 1991 Apr; 26(4):643-5. PubMed ID: 1831064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dibenzocycloalkenimine (MK-801) stimulates phosphoinositide hydrolysis in rat cerebral cortical slices).
    Ormandy GC; Li X; Jope RS
    Neuropharmacology; 1990 Aug; 29(8):779-82. PubMed ID: 2177162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of anosmia on MK-801-induced behaviour in mice.
    Andiné P; Axelsson R; Jacobson I
    Neurosci Lett; 1995 May; 190(2):113-6. PubMed ID: 7644117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the NMDA-antagonist, MK-801, on stress-induced alterations of dopamine dependent behavior.
    Mele A; Cabib S; Oliverio A
    Psychopharmacology (Berl); 1995 Feb; 117(3):313-7. PubMed ID: 7770607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
    Sharma AC; Thorat SN; Nayar U; Kulkarni SK
    Indian J Physiol Pharmacol; 1991 Apr; 35(2):111-6. PubMed ID: 1838740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats.
    Scalzo FM; Burge LJ
    Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Destruction of the noradrenergic system with DSP4 potentiates the behavioral effects of MK-801 in rats.
    Hatip-Al-Khatib I; Bolukbasi F
    Pharmacol Biochem Behav; 1999 Feb; 62(2):233-7. PubMed ID: 9972689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.
    Bubeníková-Valesová V; Votava M; Pálenícek T; Horácek J
    Neuropharmacology; 2007 Mar; 52(4):1071-8. PubMed ID: 17196227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.
    Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1992; 107(4):591-4. PubMed ID: 1534911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct effects of MK-801 and (+/-)-2-amino-5-phosphonopentanoic acid on N-methyl-D-aspartate-induced rise of brain temperature in rats.
    Hara S; Mukai T; Kuriiwa F; Iwata N; Yanase T; Kano S; Endo T
    Life Sci; 1997; 61(20):PL 289-94. PubMed ID: 9366516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.